HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short-and long-term treatment in anti-TNF naive patients

Journal article published in 2015 by Marina Talamonti

, Elisabetta Botti, Antonio Costanzo, Sergio Chimenti

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload